A Clinical Investigation Core is an essential component of a multi- disciplinary HIV research program which fosters translational research through collaboration between clinical and basic scientists. Observations made in the basic science laboratory may merit validation and hypothesis may warrant testing with well characterized clinical specimens from HIV- infected patients. Diagnostic assays which are often developed from laboratory strains of organisms require evaluation with clinical isolates. Some translational research questions can be adequately addressed through analysis of stored specimens, but many require the prospective collection of fresh blood in select populations and specialized processing which is optimally coordinated and conducted by an experienced set of investigators and staff. The objective of the Clinical Investigation Core is to provide access of HIV patient specimens and clinical trials expertise to laboratory and clinical scientists studying HIV pathogenesis and associated opportunistic infections. A secondary objective of the Core is to provide access of specimens to investigators developing diagnostic assays for patient recruitment services including outreach to women, minorities and infection drug users, b) consultation on study design and analysis, c) acquisition of clinical specimens, and d) data entry and collection. The Clinical Investigation Core will promoter AIDS translational research by offering expert consultation by experiencing clinical investigators at an established HIV clinical research unit and access to participants in vaccine, anti-retroviral immune modulator, HIV primary infection, and opportunistic infection protocols. The Core will also permit the use of an established and experienced clinical research unit to obtain and distribute specimens for laboratory based research. The proposed Clinical Investigation Core will provide new opportunities for HIV investigators to study pathogenesis of HIV and associated infections.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Center Core Grants (P30)
Project #
3P30AI036214-08S1
Application #
6500687
Study Section
Project Start
2001-09-30
Project End
2002-05-31
Budget Start
Budget End
Support Year
8
Fiscal Year
2001
Total Cost
$180,480
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Naticchia, Matthew R; Laubach, Logan K; Tota, Ember M et al. (2018) Embryonic Stem Cell Engineering with a Glycomimetic FGF2/BMP4 Co-Receptor Drives Mesodermal Differentiation in a Three-Dimensional Culture. ACS Chem Biol 13:2880-2887
Blumenthal, Jill; Jain, Sonia; Mulvihill, Evan et al. (2018) Perceived versus calculated HIV risk: Implications for Pre-exposure prophylaxis uptake in a randomized trial of men who have sex with men. J Acquir Immune Defic Syndr :
Kardava, Lela; Sohn, Haewon; Youn, Christine et al. (2018) IgG3 regulates tissue-like memory B cells in HIV-infected individuals. Nat Immunol 19:1001-1012
Wagner, Karla D; Syvertsen, Jennifer L; Verdugo, Silvia R et al. (2018) A mixed methods study of the social support networks of female sex workers and their primary noncommercial male partners in Tijuana, Mexico. J Mix Methods Res 12:437-457
Bastos, Francisco I; Bastos, Leonardo Soares; Coutinho, Carolina et al. (2018) HIV, HCV, HBV, and syphilis among transgender women from Brazil: Assessing different methods to adjust infection rates of a hard-to-reach, sparse population. Medicine (Baltimore) 97:S16-S24
Cepeda, Javier A; Eritsyan, Ksenia; Vickerman, Peter et al. (2018) Potential impact of implementing and scaling up harm reduction and antiretroviral therapy on HIV prevalence and mortality and overdose deaths among people who inject drugs in two Russian cities: a modelling study. Lancet HIV 5:e578-e587
Namazi, Golnaz; Fajnzylber, Jesse M; Aga, Evgenia et al. (2018) The Control of HIV After Antiretroviral Medication Pause (CHAMP) Study: Posttreatment Controllers Identified From 14 Clinical Studies. J Infect Dis 218:1954-1963
Lada, Steven M; Huang, Karissa; VanBelzen, D Jake et al. (2018) Quantitation of Integrated HIV Provirus by Pulsed-Field Gel Electrophoresis and Droplet Digital PCR. J Clin Microbiol 56:
Huang, Mia L; Michalak, Austen L; Fisher, Christopher J et al. (2018) Small Molecule Antagonist of Cell Surface Glycosaminoglycans Restricts Mouse Embryonic Stem Cells in a Pluripotent State. Stem Cells 36:45-54
Skaathun, Britt; Voisin, Dexter R; Cornwell, Benjamin et al. (2018) A Longitudinal Examination of Factors Associated with Network Bridging Among YMSM: Implications for HIV Prevention. AIDS Behav :

Showing the most recent 10 out of 921 publications